Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep;45(17-18):1546-1554.
doi: 10.1002/elps.202400036. Epub 2024 May 24.

An immuno-northern technique to measure the size of dsRNA byproducts in in vitro transcribed RNA

Nathaniel E Clark  1 , Matthew R Schraut  1 , Roger A Winters  1 , Kelley Kearns  1 , Thomas C Scanlon  1
Affiliations

An immuno-northern technique to measure the size of dsRNA byproducts in in vitro transcribed RNA

Nathaniel E Clark et al. Electrophoresis. 2024 Sep.

Abstract

Double-stranded RNA is an immunogenic byproduct present in RNA synthesized with in vitro transcription. dsRNA byproducts engage virus-sensing innate immunity receptors and cause inflammation. Removing dsRNA from in vitro transcribed messenger RNA (mRNA) reduces immunogenicity and improves protein translation. Levels of dsRNA are typically 0.1%-0.5% of total transcribed RNA. Because they form such a minor fraction of the total RNA in transcription reactions, it is difficult to confidently identify discrete bands on agarose gels that correspond to the dsRNA byproducts. Thus, the sizes of dsRNA byproducts are largely unknown. Total levels of dsRNA are typically assayed with dsRNA-specific antibodies in ELISA and immuno dot-blot assays. Here we report a dsRNA-specific immuno-northern blot technique that provides a clear picture of the dsRNA size distributions in transcribed RNA. This technique could complement existing dsRNA analytical methods in studies of dsRNA byproduct synthesis, dsRNA removal, and characterization of therapeutic RNA drug substances.

Keywords: J2 mAb; dsRNA; immuno‐northern blot; in vitro transcription; mRNA.

PubMed Disclaimer

References

REFERENCES

    1. Kariko K, Buckstein M, Ni H, Weissman D. Suppression of RNA recognition by toll‐like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity. 2005;23(2):165–175.
    1. Kariko K, Muramatsu H, Ludwig J, Weissman D. Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside‐modified, protein‐encoding mRNA. Nucleic Acids Res. 2011;39(21):e142.
    1. Karikó K, Ni H, Capodici J, Lamphier M, Weissman D. mRNA is an endogenous ligand for toll‐like receptor 3. J Biol Chem. 2004;279(13):12542–12550.
    1. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double‐stranded RNA and activation of NF‐kappaB by toll‐like receptor 3. Nature. 2001;413(6857):732–738.
    1. Chen YG, Hur S. Cellular origins of dsRNA, their recognition and consequences. Nat Rev Mol Cell Biol. 2022;23(4):286–301.

MeSH terms

LinkOut - more resources